TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ferring Läkemedel AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,708
|
19,113
|
21,338 |
| Financial expenses |
121
|
114
|
59 |
| Earnings before taxes |
468
|
540
|
361 |
| EBITDA |
577
|
647
|
438 |
| Total assets |
8,652
|
9,826
|
10,082 |
| Current assets |
8,583
|
9,755
|
10,035 |
| Current liabilities |
3,863
|
5,401
|
6,163 |
| Equity capital |
2,773
|
2,502
|
2,182 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
22
|
19
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
32.1%
|
25.5%
|
21.6% |
| Turnover per employee |
805
|
1,006
|
1,185 |
| Profit as a percentage of turnover |
2.6%
|
2.8%
|
1.7% |
| Return on assets (ROA) |
6.8%
|
6.7%
|
4.2% |
| Current ratio |
222.2%
|
180.6%
|
162.8% |
| Return on equity (ROE) |
16.9%
|
21.6%
|
16.5% |
| Change turnover |
-755
|
-2,286
|
1,145 |
| Change turnover % |
-4%
|
-11%
|
6% |
| Chg. No. of employees |
3
|
1
|
-1 |
| Chg. No. of employees % |
16%
|
6%
|
-5% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.